Due to health issues, this site is no longer maintained and will be shut down shortly.


Develops novel therapeutics to treat diseases of the eye

$24.06  -0.11 (-0.46%)
As of 03/27/2023 14:18:02 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  09/18/2018
Outstanding shares:  137,122,338
Average volume:  2,294,184
Market cap:   $3,251,170,634
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BK8Y8K9
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy